Vol. 23 No. 2 (2019)
CORONARY ARTERY DISEASES

Risk factors for the return of mitral insufficiency after coronary artery bypass graft and reconstruction of the mitral valve in patients with ischemic cardiomyopathy

Yu. Kareva
Meshalkin National Medical Research Center, Novosibirsk, Russian Federation
V. Efendiev
Bayandin Murmansk Regional Clinical Hospital, Murmansk, Russian Federation
S. Rakhmonov
Meshalkin National Medical Research Center, Novosibirsk, Russian Federation
Bio
A. Chernyavskiy
Meshalkin National Medical Research Center, Novosibirsk, Russian Federation
V. Lukinov
Institute of Computational Mathematics and Mathematical Geophysics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russian Federation; Siberian State University of Telecommunications and Information Sciences, Novosibirsk, Russian Federation

Published 2019-10-15

Keywords

  • coronary artery bypass graft,
  • ischemic cardiomyopathy,
  • ischemic mitral insufficiency

How to Cite

Kareva, Y., Efendiev, V., Rakhmonov, S., Chernyavskiy, A., & Lukinov, V. (2019). Risk factors for the return of mitral insufficiency after coronary artery bypass graft and reconstruction of the mitral valve in patients with ischemic cardiomyopathy. Patologiya Krovoobrashcheniya I Kardiokhirurgiya, 23(2), 31–42. https://doi.org/10.21688/1681-3472-2019-2-31-42

Abstract

Aim. This study aimed to compare the surgical correction results for isolated coronary artery bypass graft (CABG) and CABG in combination with mitral valve (MV) repair for moderate ischemic mitral insufficiency (IMI) in patients with ischemic cardiomyopathy and to identify the risk factors for MI return.
Methods. This single-centre prospective study enrolled 76 patients with ischemic cardiomyopathy and moderate MI with a left ventricular ejection fraction < 35% who did not undergo left ventricular reconstruction. The patients were treated with isolated CABG or CABG in combination with MV repair. The mean age of the patients was 57.5 ± 8.6 years (range, 30–75 years), and 90% were men. Isolated annuloplasty was used with a rigid support ring brand with a ring size of 26–30 mm to correct mitral insufficiency in the CABG + MV repair group.
Results. We found that isolated CABG or CABG + MV repair in patients with ischemic heart disease and severe systolic left ventricular dysfunction does not result in significant decrease in the MI in the long term compared with that at baseline. However, the degree of MI after CABG + MV repair is lower than the initial values, unlike that after isolated CABG 12 months postoperatively. In the observation period, of up to 36 months, the MI degree after isolated CABG corresponds to the initial values. The determination of the predictors of IMI progression in ischemic cardiomyopathy enabled us to determine the threshold values of the performance indicators of MV repair, and the evaluation of Echo predictors for annuloplasty preoperatively help select the surgical treatment strategies for patients with ischemic cardiomyopathy and moderate MI.
Conclusion. Correction of IMI in patients with ischemic cardiomyopathy does not increase the number of complications in the early postoperative period compared to isolated CABG (p = 0.015). After isolated CABG in patients with ischemic cardiomyopathy and moderate MI, progression of mitral regurgitation (grade 3 mitral regurgitation, initially 0%; after 12 months, 31%; after 36 months, 71%; p < 0.001) is observed even with initially moderate changes in the geometry of the mitral valve.

Received 6 December 2018. Revised 25 March 2019. Accepted 28 March 2019.

Funding: The study did not have sponsorship.

Conflict of interest: Authors declare no conflict of interest.

References

  1. Trichon B.H., Felker G.M., Shaw L.K., Cabell C.H., O'Connor C.M. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol. 2003;91(5):538-43. PMID: 12615256. https://doi.org/10.1016/s0002-9149(02)03301-5
  2. Unger P., Magne J., Dedobbeleer C., Lancellotti P. Ischemic mitral regurgitation: not only a bystander. Curr Cardiol Rep. 2012;14(2):180-9. PMID: 22203438. https://doi.org/10.1007/s11886-011-0241-y
  3. Grigioni F., Avierinos J.F., Ling L.H., Scott C.G., Bailey K.R., Tajik A.J., Frye R.L., Enriquez-Sarano M. Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome. J Am Coll Cardiol. 2002;40(1):84-92. PMID: 12103260. http://doi.org/10.1016/s0735-1097(02)01922-8
  4. Grigioni F., Enriquez-Sarano M., Ling L.H., Bailey K.R., Seward J.B., Tajik A.J., Frye R.L. Sudden death in mitral regurgitation due to flail leaflet. J Am Coll Cardiol. 1999;34(7):2078-85. PMID: 10588227. http://doi.org/10.1016/s0735-1097(99)00474-x
  5. Marchenko A., Cherniavsky A., Volokitina T., Alsov, S., Karaskov A. Left ventricular dimension and shape after postinfarction aneurysm repair. Eur J Cardiothorac Surg. 2005;27(3):475-80. https://doi.org/10.1016/j.ejcts.2004.12.025
  6. Rogers J.H., Bolling S.F. What to do with functional mitral regurgitation: what do we really know and how can we find out? Eur J Cardiothorac Surg. 2012;42(6):915-7. PMID: 23041552. https://doi.org/10.1093/ejcts/ezs472
  7. Bolling S.F., Pagani F.D., Deeb G.M., Bach D.S. Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg. 1998;115(2):381-8. PMID: 9475533. https://doi.org/10.1016/s0022-5223(98)70282-x
  8. Krishnaswamy A., Gillinov A.M., Griffin B.P. Ischemic mitral regurgitation: pathophysiology, diagnosis, and treatment. Coron Artery Dis. 2011;22(5):359-70. PMID: 21572322. http://doi.org/10.1097/mca.0b013e3283441d3f
  9. Braun J., Klautz R. Functional mitral regurgitation: the surgeons’ perspective. In: Bartunek J., Vanderheyden M., editors. Translational Approach to Heart Failure. New York: Springer; 2013. pp. 241-90. https://doi.org/10.1007/978-1-4614-7345-9_10
  10. Castleberry A.W., Williams J.B., Daneshmand M.A., Honeycutt E., Shaw L.K., Samad Z., Lopes R.D., Alexander J.H., Mathew J.P., Velazquez E.J., Milano C.A., Smith P.K. Surgical revascularization is associated with maximal survival in patients with ischemic mitral regurgitation: a 20-year experience. Circulation. 2014;129(24):2547-56. http://doi.org/10.1161/circulationaha.113.005223
  11. Cohn J.N., Tognoni G., Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med. 2001;345(23)1667-75. PMID: 11759645. http://doi.org/10.1056/nejmoa010713
  12. Чернявский А.М., Ефремова О.С., Рузматов Т.М., Эфендиев В.У. Предикторы отдаленной летальности больных ишемической болезнью сердца с выраженной левожелудочковой дисфункцией. Патология кровообращения и кардиохирургия. 2015;19(2):49-54. http://dx.doi.org/10.21688/1681-3472-2015-2-49-54 [Cherniavsky A.M., Yefremova O.S., Ruzmatov T.M., Efendiyev V.U. Predictors of remote mortality of CHD patients with severe left ventricular dysfunction. Patologiya krovoobrashcheniya i kardiokhirurgiya = Circulation Pathology and Cardiac Surgery. 2015;19(2):49-54. (In Russ.). http://dx.doi.org/10.21688/1681-3472-2015-2-49-54]
  13. Grigioni F., Enriquez-Sarano M., Zehr K.J., Bailey K.R., Tajik A.J. Ischemic mitral regurgitation long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation. 2001;103(13):1759-64. PMID: 11282907.
  14. Kron I.L., Hung J., Overbey J.R., Bouchard D., Gelijns A.C., Moskowitz A.J., Voisine P., O'Gara P.T., Argenziano M., Michler R.E., Gillinov M., Puskas J.D., Gammie J.S., Mack M.J., Smith P.K., Sai-Sudhakar C., Gardner T.J., Ailawadi G., Zeng X., O'Sullivan K., Parides M.K., Swayze R., Thourani V., Rose E.A., Perrault L.P., Acker M.A.; CTSN Investigators. Predicting recurrent mitral regurgitation after mitral valve repair for severe ischemic mitral regurgitation. J Thorac Cardiovasc Surg. 2015;149(3):752-61.e1. PMID: 25500293, PMCID: PMC4687890. http://doi.org/10.1016/j.jtcvs.2014.10.120
  15. Jeong D.S., Lee H.Y., Kim W.S., Sung K., Park P.W., Lee Y.T. Off pump coronary artery bypass versus mitral annuloplasty in moderate ischemic mitral regurgitation. Ann Thorac Cardiovasc Surg. 2012;18(4):322-30. http://doi.org/10.5761/atcs.oa.11.01845
  16. McMurray J.J., Adamopoulos S., Anker S.D., Auricchio A., Böhm M., Dickstein K., Falk V., Filippatos G., Fonseca C., Gomez-Sanchez M.A., Jaarsma T., Køber L., Lip G.Y., Maggioni A.P., Parkhomenko A., Pieske B.M., Popescu B.A., Rønnevik P.K., Rutten F.H., Schwitter J., Seferovic P., Stepinska J., Trindade P.T., Voors A.A., Zannad F., Zeiher A.; Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology, Bax J.J., Baumgartner H., Ceconi C., Dean V., Deaton C., Fagard R., Funck-Brentano C., Hasdai D., Hoes A., Kirchhof P., Knuuti J., Kolh P., McDonagh T., Moulin C., Popescu B.A., Reiner Z., Sechtem U., Sirnes P.A., Tendera M., Torbicki A., Vahanian A., Windecker S., McDonagh T., Sechtem U., Bonet L.A., Avraamides P., Ben Lamin H.A., Brignole M., Coca A., Cowburn P., Dargie H., Elliott P., Flachskampf F.A., Guida G.F., Hardman S., Iung B., Merkely B., Mueller C., Nanas J.N., Nielsen O.W., Orn S., Parissis J.T., Ponikowski P.; ESC Committee for Practice Guidelines. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur J Heart Fail. 2012;14(8):803-69. PMID: 22828712. http://doi.org/10.1093/eurjhf/hft016
  17. Fattouch K., Sampognaro R., Speziale G., Salardino M., Novo G., Caruso M., Novo S., Ruvolo G. Impact of moderate ischemic mitral regurgitation after isolated coronary artery bypass grafting. Ann Thorac Surg. 2010;90(4):1187-94. PMID: 20868812. http://doi.org/10.1016/j.athoracsur.2010.03.103
  18. Di Mauro M., Di Giammarco G., Vitolla G., Contini M., Iacò A.L., Bivona A., Weltert L., Calafiore A.M. Impact of no-to moderate mitral regurgitation on late results after isolated coronary artery bypass grafting in patients with ischemic cardiomyopathy. Ann Thorac Surg. 2006;81(6):2128-34. PMID: 16731141. http://doi.org/10.1016/j.athoracsur.2006.01.061
  19. De Simone R., Wolf I., Mottl-Link S., Hoda R., Mikhail B., Sack F.U., Meinzer H.P., Hagl S. A clinical study of annular geometry and dynamics in patients with ischemic mitral regurgitation: new insights into asymmetrical ring annuloplasty. Eur J Cardiothorac Surg. 2006;29(3):355-361. PMID: 16439153. http://doi.org/10.1016/j.ejcts.2005.12.034